Orthopedic surgery transfusion hemoglobin european overview (OSTHEO) study: Blood management in elective knee and hip arthroplasty in Europe

Transfusion

Volumn 43, Issue 4, 2003, Pages 459-469

  Rosencher, Nadia ^a   Kerkkamp, Hans E M ^b   Macheras, G ^b   Munuera, L M ^b   Menichella, G ^b   Barton, David M ^b   Cremers, Saskia ^b   Abraham, Ivo L ^b  

^a Hôpital Cochin ^*  (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK FACTOR; SEX DIFFERENCE; TREATMENT PLANNING; WOUND INFECTION;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD SPECIMEN COLLECTION; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; EUROPE; FEMALE; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 0037390545     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00348.x     Document Type: Article

References (25)

1. Birkmeyer JD, Goodnough LT, Aubuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993;33:544-51.
2. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24.
3. Murphy P, Heal J, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991;31:212-7.
4. Innerhofer P, Walleczek C, Luz G, et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999;39:625-32.
5. Faris P, Spence R, Larholt K, Sampson A, Frei D. The predictive power of baseline hemoglobin for transfusion risk in surgery patients. Orthopedics 1999;22(1 Suppl):s135-40.
6. Goodnough LT, Brecher M, Kanter MH, Aubuchon JP. Transfusion medicine: second of two parts - blood conservation. N Engl J Med 1999;340:525-33.
7. Brecher M, Monk T, Goodnough L. A standardized method for calculating blood loss. Transfusion 1997;37:70-4.
8. Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996;13:465-78.
9. SPSS RM 9.0. T. Chicago: SPSS Inc.; 1999:36.
10. AuBuchon JP, Popovsky MA. The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion 1991;31:513-7.
11. Bierbaum B, Callaghan J, Galante J, et al. Analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999;81:2-10.
12. Forgie M, Wells P, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 1998;158:610-6.
13. Bryson G, Laupacis A, Wells G. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 1998;86:9-15.
14. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-8.
15. Mercuriali F. Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery. Semin Hematol 1996;33:10-2.
16. Goldberg M. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. Semin Hematol 1997;34(3 Suppl 1):41-7.
17. Biesma DH, Marx JJ, Kraaijenhagen RJ, et al. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin. Lancet 1994;344:367-70.
18. Jarolem K, Scott D, Jaffe W, et al. A comparison of blood loss and transfusion requirements in total knee arthroplasty with and without arterial tourniquet. Am J Orthop 1995;24:906-9.
19. Wallace E, Surgenor D, Hao H, et al. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993;33:139-44.
20. Stevens C, Aach R, Hollinger F, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984;101:733-8.
21. Borghi B, Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia. Eur J Anaesthesiol 2000;17:411-7.
22. Faris PM, Ritter MA, Keating EM, Valeri CR. Unwashed filtered shed blood collected after knee and hip arthroplasty. J Bone Joint Surg Am 1991;73:1169-78.
23. Martin JW, Whiteside LA, Milliano MT, Reedy ME. Postoperative blood retrieval and transfusion in total knee arthroplasty. J Arthroplasty 1992;7:205-10.
24. Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996;13:465-87.
25. Brecher ME, Monk T, Goodnough LT. A standardized method for calculating blood loss. Transfusion 1997;37:1070-4.